Skip to content

BioAmber Inc.

CIK 0001534287

← back to feed
Revenue (TTM)
$4.69M
+63.5% YoY FY Mar 2018
Net Income (TTM)
−$20.24M
−1,092.6% YoY FY Mar 2018
EPS Diluted (TTM)
−$0.43
FY Mar 2018
Gross Margin
-63.8%
FY Mar 2018
Operating Margin
-705.5%
FY Mar 2018
Net Margin
-431.7%
FY Mar 2018
Free Cash Flow (TTM)
−$63.74M
FY Mar 2018
Cash
$4.63M
FY Mar 2018
Total Debt
$37.62M
FY Mar 2018
Shares Outstanding
129.45M sh
FY Mar 2018

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings